Pari Mody

Partner at Arnold & Porter

Speaker

Pari Mody practices at the intersection of law and public policy, representing clients across the life sciences sector, including small- and mid-size biotechs, established drug and device manufacturers, and trade associations. Her practice focuses primarily on issues related to pharmaceutical pricing, Medicare and Medicaid coverage and reimbursement, and the 340B Program. Pari has particular expertise with emergent drug pricing initiatives, including the Inflation Reduction Act of 2022, most-favored-nation drug pricing models, and state Prescription Drug Affordability Boards. Pari is adept at navigating the legislative and regulatory processes, drafting legislative language, preparing comment letters, and developing and implementing legislative and regulatory strategies. She also frequently advises clients on administrative law matters, including Administrative Procedure Act litigation.